Article
Whole-blood phenotyping to assess alloimmunization status in transfused sickle cell disease patients.
Blood advances - 9 Mar 2021
Tamagne Marie, Pakdaman Sadaf, Bartolucci Pablo, Habibi Anoosha, Galactéros Frédéric, Pirenne France, Vingert Benoît
Abstract excerpt
It is essential to limit hemolytic transfusion reactions in polytransfused individuals, and the prevention of alloimmunization is a key solution. CD4+ T lymphocyte (TL) markers, particularly follicular T helper (Tfh) cells, may differentiate between responder and nonresponder alloimmunization statuses. We tested this hypothesis by studying the phenotype of CXCR5+PD1+ TLs in whole blood. Our results suggest that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
